Exercise Testing in Diseases and Health

Sponsor
The Baruch Padeh Medical Center, Poriya (Other)
Overall Status
Recruiting
CT.gov ID
NCT05263687
Collaborator
(none)
1,000
1
1
100
10

Study Details

Study Description

Brief Summary

Cardiopulmonary exercise test (CPET) is a helpful tool for evaluation of aerobic exercise capacity and tolerance for variety of population. CPET provides a full assessment of the physiologic responses of the pulmonary, cardiovascular, muscular, and cellular oxidative systems to exercise. The test progression include a incremental stepwise (on treadmill) or ramp control protocol (on bike ergometer ) to exhaustion. Measurement of respiratory gas exchange i.e. oxygen uptake, carbon dioxide, minute ventilation, other variables while monitoring ECG, blood pressure, pulse oximetry and exertion perceived (Borg Scale) during an incremental test .

Aim: To compere exercise responses for maximal exercise testing with different population.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Maximal exercise test
N/A

Detailed Description

Each participants will conducted an exercise test on treadmill using Modified Bruce Protocol) or cycle ergometer. Quark CPET metabolic cart (Cosmed, Rome, Italy) will be use to collect and analysis gas exchange. 10 minute after the graded exercise test Supra maximal exercise test (SMT) will be done for 2 minutes one stage (treadmill protocol) or 10% at cycle protocol higher than highest load achieved in the incremental test.

all outcome measurement will be collected. Exercise tolerance and responses will be assess using the data of : pulmonary gas exchange; cardiovascular performance, and skeletal muscle metabolism.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Cardio Pulmonary Exercise Testing (CPET) in Diseases and Health
Actual Study Start Date :
Aug 30, 2017
Anticipated Primary Completion Date :
Mar 19, 2025
Anticipated Study Completion Date :
Dec 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise Test

maximal and anaerobic threshold cardiopulmonary parameters

Diagnostic Test: Maximal exercise test
Each participants will conduct a spirometry test and exercise test on treadmill (using Modified Bruce Protocol) or cycle ergometer. Quark CPET metabolic cart (Cosmed, Rome, Italy) will be used to collect and analysis gas exchange, ECG, gas volume in addition rating of perceived exertion will be asked.

Outcome Measures

Primary Outcome Measures

  1. Maximal Oxygen consumption [through study completion, an average of 1 year]

    the maximum amount of oxygen that an individual can utilize during intense or maximal exercise.

  2. Maximal Heart rate [through study completion, an average of 1 year]

    the maximum heart rate achieved during intense or maximal exercise.

  3. Maximal Blood pressure [through study completion, an average of 1 year]

    the blood pressure in the end of intense or maximal exercise.

Secondary Outcome Measures

  1. Ventilation Anaerobic Threshold [through study completion, an average of 1 year]

    Ventilatory Threshold (VT) describes the inflection point for ventilation during an incremental exercise test.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

*Patient who invited to the clinic to do incremental maximal exercise test or healthy *Participants with no known significant health problems.

Exclusion Criteria:
  • Acute fever

  • Acute myocardial infarction within 2 to 3 days.

  • Unstable angina not previously stabilized by medical therapy.

  • Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise.

  • Symptomatic severe aortic stenosis.

  • Uncontrolled symptomatic heart failure.

  • Inability to perform exercise Orthopedic impairment severely compromising exercise performance.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The BARUCH PADEH Medical Center, Poriya Teverya The Lower Galilee Israel 15208

Sponsors and Collaborators

  • The Baruch Padeh Medical Center, Poriya

Investigators

  • Principal Investigator: Gur Mainzer, MD, The Baruch Padeh Medical Center, Poriya

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gur Mainzer, Head of the pediatric cardiology department, The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT05263687
Other Study ID Numbers:
  • 0033-17-POR
First Posted:
Mar 2, 2022
Last Update Posted:
Mar 21, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 21, 2022